Pharmacist-led guideline-directed medical therapy in heart failure: impact analysis in primary care

Markus Schichtel1, Stephen Barclay2, Helena Papworth3

  • 1Department of Public Health and Primary Care, University of Cambridge, Cambridge, England, UK ms2591@cam.ac.uk.

BMJ Open Quality
|September 1, 2025
PubMed

Insights

A pharmacist-led heart failure (HF) management model significantly increased guideline-directed medical therapy (GDMT) rates in primary care. This approach reduced healthcare costs, GP workload, mortality, and hospitalizations, improving patient quality of life.

Area of Science:

  • Cardiology and Primary Care Medicine
  • Pharmacist-led Health Interventions
  • Health Services Research

Background:

  • Guideline-directed medical therapy (GDMT) for heart failure (HF) improves outcomes but is underused in UK primary care.
  • Limited GP capacity and increasing HF burden necessitate innovative care models.
  • Suboptimal GDMT contributes to preventable mortality and hospital admissions.

Purpose of the Study:

  • To evaluate a novel pharmacist-led GDMT model for optimizing HF care in UK primary care.
  • To assess the impact on GDMT rates, healthcare costs, GP workload, mortality, and quality of life.

Main Methods:

  • A multisite, quantitative impact analysis involving 237 low-risk HF patients.
  • Utilized the HF Event STrengthening Score for patient identification.
  • Compared optimal GDMT rates, costs, and workload at baseline, 6 months, and 2 years.

Main Results:

  • Optimal GDMT increased from 17.7% at baseline to 76.5% at 6 months and 94.5% at 2 years.
  • Reduced GP workload by 36.6% (6 months) and 42.1% (2 years); healthcare costs by 18.4% (6 months) and 20.3% (2 years).
  • Subgroup analysis showed reduced cardiovascular mortality (20.8%), hospitalizations (34.8%), and improved quality of life (5.31 KCQ score).

Conclusions:

  • Pharmacist-led GDMT optimization significantly improves treatment rates for low-risk HF patients.
  • This model effectively reduces healthcare costs and GP workload.
  • The approach shows potential for widespread implementation to improve HF patient outcomes and manage workload pressures.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505